GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 51 filers reported holding GALENA BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 2,465,860 | $1,504,000 | 0.08% |
| DAFNA Capital Management LLC | 46,145 | $28,000 | 0.02% |
| EQUITEC SPECIALISTS, LLC | 174,500 | $106,000 | 0.02% |
| Nine Chapters Capital Management LLC | 21,000 | $13,000 | 0.02% |
| Airain ltd | 86,248 | $53,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 55,949 | $34,000 | 0.00% |
| EQUITEC SPECIALISTS, LLC | 22,500 | $14,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,886 | $8,000 | 0.00% |
| QUADRANT CAPITAL GROUP LLC | 5,094 | $3,000 | 0.00% |
| Renaissance Technologies | 1,600,275 | $976,000 | 0.00% |